GlassScriptPhysician profile
Ashley Anders Schroeder
NPI 1154391829
$2,036.81
in general payments reported to CMS, 2019-2025
11 companies · $577 in 2025
The $577 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2021: $149 · 2022: $401 · 2023: $84.33 · 2024: $509 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $863.92 | 2022-2025 | |
| Intersect Ent, INC. | $220.69 | 2019-2021 | |
| Medtronic, INC. | $202.76 | 2024-2025 | Nim Vital, Propel |
| Stryker Corporation | $142.85 | 2022 | |
| Oticon Medical, LLC | $131.73 | 2024 | Ponto Bone Anchored Hearing System |
| Acclarent, INC | $122.77 | 2019 | |
| Glaxosmithkline, LLC. | $122.04 | 2021 | |
| Inspire Medical Systems, INC. | $106.17 | 2025 | Inspire |
| Olympus America INC. | $61.83 | 2023 | Rhino-Laryngo Videoscope |
| Acera Surgical, INC. | $39.55 | 2025 | Restrata Wound Matrix |
| Regeneron Healthcare Solutions, INC. | $22.50 | 2023 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Schroeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.